Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2001-11-7
pubmed:abstractText
To investigate the genetic susceptibility associated with cough related to angiotensin-converting enzyme inhibitor (ACEI) therapy in patients with type 2 diabetes, 189 non-insulin-dependent diabetes mellitus (NIDDM) patients with proteinuria or hypertension treated with perindopril were studied. Cough was considered to be present if the patients had been bothered by a cough during treatment and if they had had related symptoms for at least 2 weeks without an identifiable cause. Polymerase chain reaction (PCR) coupled with single-strand conformation polymorphism (SSCP) was used to detect polymorphisms of ACE and bradykinin B2-receptor genes. After 8 weeks of treatment, 49.2% (93 of 189) of our NIDDM patients were found to be suffering from ACEI-related cough. ACEI-related cough was mainly associated with female patients, with 71.7% (76 of 106) of female and only 20.5% (17 of 83) of male patients experiencing cough after ACEI treatment. There was a significant association of ACE II genotype with ACEI-related cough. The genotype frequencies were 58.2% for II, 47.8% for ID, and 16.7% for DD in patients with ACEI-associated cough and 41.8% for II, 52.2% for ID, and 83.3% for DD in subjects without ACEI-associated cough (chi(2) = 10.268; df = 2, P =.006). As female patients made up the majority of the subjects suffering from ACEI-related cough, we further analyzed the association of ACE I/D genotype with ACEI-related cough separately by sex. Male patients with ACEI-related cough were not associated with ACE I/D genotype distribution, while female patients were strongly associated with ACE I/D genotype polymorphism (chi(2) = 16.12; df = 2; P <.001). There was no association between the bradykinin B2 receptor gene -58T/C polymorphism with ACEI-related cough. In conclusion, our results indicate that Chinese diabetic female subjects are susceptible to ACEI-related cough, and this susceptibility may be genetically predetermined.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0026-0495
pubmed:author
pubmed:copyrightInfo
Copyright 2001 by W.B. Saunders Company
pubmed:issnType
Print
pubmed:volume
50
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1346-50
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:11699055-Angiotensin-Converting Enzyme Inhibitors, pubmed-meshheading:11699055-Case-Control Studies, pubmed-meshheading:11699055-Comorbidity, pubmed-meshheading:11699055-Cough, pubmed-meshheading:11699055-Diabetes Mellitus, Type 2, pubmed-meshheading:11699055-Female, pubmed-meshheading:11699055-Genetic Predisposition to Disease, pubmed-meshheading:11699055-Genotype, pubmed-meshheading:11699055-Humans, pubmed-meshheading:11699055-Hypertension, pubmed-meshheading:11699055-Male, pubmed-meshheading:11699055-Middle Aged, pubmed-meshheading:11699055-Peptidyl-Dipeptidase A, pubmed-meshheading:11699055-Perindopril, pubmed-meshheading:11699055-Polymerase Chain Reaction, pubmed-meshheading:11699055-Polymorphism, Genetic, pubmed-meshheading:11699055-Polymorphism, Single-Stranded Conformational, pubmed-meshheading:11699055-Prevalence, pubmed-meshheading:11699055-Proteinuria, pubmed-meshheading:11699055-Receptor, Bradykinin B2, pubmed-meshheading:11699055-Receptors, Bradykinin, pubmed-meshheading:11699055-Sex Distribution, pubmed-meshheading:11699055-Taiwan
pubmed:year
2001
pubmed:articleTitle
Angiotensin-converting enzyme gene insertion/deletion, not bradykinin B2 receptor -58T/C gene polymorphism, associated with angiotensin-converting enzyme inhibitor-related cough in Chinese female patients with non-insulin-dependent diabetes mellitus.
pubmed:affiliation
Department of Clinical Research, Ping-Tung Christian Hospital, Ping-Tung, Taiwan, Republic of China.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't